These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34728235)

  • 21. Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas.
    Sarek G; Ma L; Enbäck J; Järviluoma A; Moreau P; Haas J; Gessain A; Koskinen PJ; Laakkonen P; Ojala PM
    Oncogene; 2013 Feb; 32(9):1091-8. PubMed ID: 22469985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myc is required for the maintenance of Kaposi's sarcoma-associated herpesvirus latency.
    Li X; Chen S; Feng J; Deng H; Sun R
    J Virol; 2010 Sep; 84(17):8945-8. PubMed ID: 20573831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of c-Myc transcriptional activity by vIRF-3 of Kaposi sarcoma-associated herpesvirus.
    Lubyova B; Kellum MJ; Frisancho JA; Pitha PM
    J Biol Chem; 2007 Nov; 282(44):31944-53. PubMed ID: 17728244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity of the synthetic retinoid ST1926 on primary effusion lymphoma in vitro and in vivo models.
    Karam L; Houshaymi B; Abdel-Samad R; Jaafar M; Halloum I; Pisano C; Neipel F; Darwiche N; Abou Merhi R
    Oncol Rep; 2018 Feb; 39(2):721-730. PubMed ID: 29207182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.
    Ning J; Wakimoto H; Peters C; Martuza RL; Rabkin SD
    J Natl Cancer Inst; 2017 Mar; 109(3):1-13. PubMed ID: 28376211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-κB.
    Gopalakrishnan R; Matta H; Chaudhary PM
    Clin Cancer Res; 2013 Sep; 19(18):5016-26. PubMed ID: 23881928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma.
    Sarosiek KA; Cavallin LE; Bhatt S; Toomey NL; Natkunam Y; Blasini W; Gentles AJ; Ramos JC; Mesri EA; Lossos IS
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13069-74. PubMed ID: 20615981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3.
    Lian X; Bao C; Li X; Zhang X; Chen H; Jung YS; Qian Y
    J Virol; 2019 May; 93(9):. PubMed ID: 30787154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chk2 deficiency in Myc overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP inhibition.
    Höglund A; Strömvall K; Li Y; Forshell LP; Nilsson JA
    Cell Cycle; 2011 Oct; 10(20):3598-607. PubMed ID: 22030621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of tumor suppressor genes by exogenous dhC16-Cer contributes to its anti-cancer activity in primary effusion lymphoma.
    Cao Y; Qiao J; Lin Z; Zabaleta J; Dai L; Qin Z
    Oncotarget; 2017 Feb; 8(9):15220-15229. PubMed ID: 28146424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.
    Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR
    PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
    Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
    mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.
    Gopalakrishnan R; Matta H; Tolani B; Triche T; Chaudhary PM
    Oncogene; 2016 Apr; 35(14):1797-810. PubMed ID: 26119939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.
    Wen KW; Damania B
    Cancer Lett; 2010 Mar; 289(2):140-50. PubMed ID: 19651473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cdk1 inhibition induces mutually inhibitory apoptosis and reactivation of Kaposi's sarcoma-associated herpesvirus.
    Li X; Chen S; Sun R
    J Virol; 2012 Jun; 86(12):6668-76. PubMed ID: 22496227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma.
    Qin Z; Dai L; Trillo-Tinoco J; Senkal C; Wang W; Reske T; Bonstaff K; Del Valle L; Rodriguez P; Flemington E; Voelkel-Johnson C; Smith CD; Ogretmen B; Parsons C
    Mol Cancer Ther; 2014 Jan; 13(1):154-64. PubMed ID: 24140934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes Virus.
    Di Domenico EG; Toma L; Bordignon V; Trento E; D'Agosto G; Cordiali-Fei P; Ensoli F
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27258263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
    Watanabe T; Fujimuro M
    Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cisplatin disrupts the latency of human herpesvirus 8 and induces apoptosis in primary effusion lymphoma cells.
    Wang YF; Chiou YH; Wang LY; Chang ST; Shyu HW; Chen CY; Lin KH; Chou MC
    Cancer Invest; 2012 May; 30(4):268-74. PubMed ID: 22480174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constitutive Activation of Interleukin-13/STAT6 Contributes to Kaposi's Sarcoma-Associated Herpesvirus-Related Primary Effusion Lymphoma Cell Proliferation and Survival.
    Wang C; Zhu C; Wei F; Zhang L; Mo X; Feng Y; Xu J; Yuan Z; Robertson E; Cai Q
    J Virol; 2015 Oct; 89(20):10416-26. PubMed ID: 26246572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.